-
News
Janssen Cilag opens collective dismissal procedure. 31 scientific informants made redundant
Janssen Cilag with registered office in Cologno Monzese (Ml), communicated today, February 24, that it has to proceed, as a consequence of…
Leggi » -
News
AlfaSigma layoffs. Proclaimed 8 hours of strike
"The pharmaceutical company AlfaSigma communicated, last February 20, a plan to substantially reduce the workforce, in particular in the scientific information of the…
Leggi » -
News
Court of Cassino. The worker can use audio recordings as evidence to prove the harassment suffered
Hidden recordings from colleagues and employer: they are valid as proof the worker, under certain conditions, can use tools…
Leggi » -
News
Consensus Conference FNOPI: what the nurse of the future will be like
The future of the nursing profession for the next twenty years is being drawn now. And the National Federation of Nursing Orders…
Leggi » -
First floor
Enasarco Foundation. Contributions cannot be reunited with other pensions and do not constitute seniority
Pensions, Enasarco contributions do not constitute insurance seniority as of 31.12.1995 Clarifications in an INPS document. Irrelevant to the…
Leggi » -
News
ANAAO ASSOMED. Doctor satisfaction survey: 1 in 3 are willing to change jobs
Survey on doctors and health managers: 1 out of 3 is willing to change jobs ANAAO ASSOMED – February 21, 2023…
Leggi » -
News
Carabinieri NAS: checks on family doctors and affiliated paediatricians, 308 irregularities detected and two studies closed
The Carabinieri NAS, in the last period, in concert with the Ministry of Health, have carried out an intense control activity, on…
Leggi » -
News
In 2022, EMA recommended 89 medicines for marketing authorisation
In 2022, EMA recommended 89 medicines for marketing authorisation. Of these, 41 had a new active ingredient…
Leggi » -
Editorial notes
After the purchase of Sofar, Alfasigma fires 333 workers, 221 of whom are informants
Alfasigma in August 2022 announced that it had reached an agreement for the acquisition of the entire share capital of Sofar Spa. Alfasigma declared that with…
Leggi » -
News
R&D spending doesn't justify high drug prices. An analysis on the BMJ
The "British medical journal" published an interesting analysis entitled "High drug prices are not ...
Leggi »